NCT06582537View on ClinicalTrials.gov

LAMA2 Genetic Correction

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

July 18, 2024

Study Completion Date

July 18, 2024

Conditions
MDC1A
Interventions
PROCEDURE

Participants sample collection

A skeletal muscle biopsy and a venous blood sample will be collected. The skin biopsy will be obtained during the incision needed for the muscle biopsy.

Trial Locations (1)

6229HX

Academisch Ziekenhuis Maastricht, Maastricht

All Listed Sponsors
lead

Maastricht University

OTHER

NCT06582537 - LAMA2 Genetic Correction | Biotech Hunter | Biotech Hunter